152 related articles for article (PubMed ID: 18848724)
21. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
Saxena V; Sadoqi M; Shao J
Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization, effect of architecture on crystallization of biodegradable poly(epsilon-caprolactone)-b-poly(ethylene oxide) copolymers with different arms and nanoparticles thereof.
Hua C; Dong CM
J Biomed Mater Res A; 2007 Sep; 82(3):689-700. PubMed ID: 17323321
[TBL] [Abstract][Full Text] [Related]
23. Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform.
Yamamoto H; Tahara K; Kawashima Y
J Microencapsul; 2012; 29(1):54-62. PubMed ID: 22034956
[TBL] [Abstract][Full Text] [Related]
24. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
[TBL] [Abstract][Full Text] [Related]
25. Surface property and in vitro biodegradation of microspheres fabricated by poly(epsilon-caprolactone-b-ethylene oxide) diblock copolymers.
Yu G; Zhang Y; Shi X; Li Z; Gan Z
J Biomed Mater Res A; 2008 Mar; 84(4):926-39. PubMed ID: 17647229
[TBL] [Abstract][Full Text] [Related]
26. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
27. Loading efficiency and surface conductance of heparin-modified poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Shih KH
Colloids Surf B Biointerfaces; 2009 Jul; 71(2):282-7. PubMed ID: 19329287
[TBL] [Abstract][Full Text] [Related]
28. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569
[TBL] [Abstract][Full Text] [Related]
29. Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride.
O'Donnell PB; McGinity JW
Eur J Pharm Biopharm; 1998 Jan; 45(1):83-94. PubMed ID: 9689539
[TBL] [Abstract][Full Text] [Related]
30. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700
[TBL] [Abstract][Full Text] [Related]
31. In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes.
Wang Z; Roberge C; Dao LH; Wan Y; Shi G; Rouabhia M; Guidoin R; Zhang Z
J Biomed Mater Res A; 2004 Jul; 70(1):28-38. PubMed ID: 15174106
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
Lee SH; Zhang Z; Feng SS
Biomaterials; 2007 Apr; 28(11):2041-50. PubMed ID: 17250886
[TBL] [Abstract][Full Text] [Related]
33. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
34. Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.
Ven HV; Vandervoort J; Weyenberg W; Apers S; Ludwig A
J Microencapsul; 2012; 29(2):115-25. PubMed ID: 22047548
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
[TBL] [Abstract][Full Text] [Related]
36. Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles.
Van de Ven H; Vermeersch M; Vandenbroucke RE; Matheeussen A; Apers S; Weyenberg W; De Smedt SC; Cos P; Maes L; Ludwig A
J Drug Target; 2012 Feb; 20(2):142-54. PubMed ID: 22080813
[TBL] [Abstract][Full Text] [Related]
37. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
[TBL] [Abstract][Full Text] [Related]
38. Protein encapsulation in biodegradable polymeric nanoparticles: morphology, fluorescence behaviour and stem cell uptake.
Rescignano N; Tarpani L; Tiribuzi R; Montesano S; Martino S; Latterini L; Kenny JM; Armentano I
Macromol Biosci; 2013 Sep; 13(9):1204-12. PubMed ID: 23776101
[TBL] [Abstract][Full Text] [Related]
39. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
40. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
Budhian A; Siegel SJ; Winey KI
Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
